Skip to content
lifestyle.hungrybear.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Cardiff Oncology, Inc.
Cardiff Oncology to Participate in the UBS Global Biopharma Conference
November 3, 2026
Cardiff Oncology Appoints Leila Alland, MD, as Interim Chief Medical Officer
October 27, 2026
Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib in Chronic Myelomonocytic Leukemia
October 21, 2026
Cardiff Oncology and Nerviano Medical Sciences Amend their 2017 Exclusive License Agreement
September 14, 2026
Cardiff Oncology to Participate in September 2026 Conferences
September 2, 2026
Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update
August 12, 2026
Cardiff Oncology Announces $10 Million Registered Direct Offering
July 15, 2026
Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update
May 14, 2026